Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free CMPO Stock Alerts

CompoSecure (CMPO) Financials

CompoSecure logo
$13.32 -0.56 (-4.03%)
As of 05/11/2026
Compare
Annual Income Statements for CompoSecure

Annual Income Statements for CompoSecure

This table shows CompoSecure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 81 78 3.15 19 19 -54 -136
Consolidated Net Income / (Loss)		 81 78 83 132 113 -83 -136
Net Income / (Loss) Continuing Operations		 81 78 83 132 113 -83 -136
Total Pre-Tax Income 		81 78 83 136 117 -81 -226
Total Operating Income		 87 84 81 115 119 108 -14
Total Gross Profit		 128 133 145 220 209 219 29
Total Revenue		 243 261 268 378 391 421 60
Operating Revenue		 243 261 268 378 391 421 60
Total Cost of Revenue		 115 128 123 159 182 201 31
Operating Cost of Revenue		 115 128 123 159 182 201 31
Total Operating Expenses		 41 49 63 105 90 112 42
Selling, General & Admin Expense		 41 49 63 105 90 112 42
Total Other Income / (Expense), net		 -5.45 -6.14 1.13 21 -2.01 -189 -212
Interest Expense		 - - - 21 28 20 1.69
Interest & Investment Income		 -4.75 -5.27 -10 1.25 4.98 4.65 1.23
Other Income / (Expense), net		 -0.70 -0.88 11 41 21 -173 -212
Income Tax Expense		 0.00 0.00 -0.86 4.36 4.56 2.19 39
Other Gains / (Losses), net		 - - - - 0.00 0.00 129
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 80 113 93 -29 0.00
Basic Earnings per Share		 $0.00 $0.00 $0.21 $1.21 $1.03 ($1.22) ($1.23)
Weighted Average Basic Shares Outstanding		 0.00 0.00 14.93M 15.37M 18.66M 44.01M 110.52M
Diluted Earnings per Share		 $0.00 $0.00 $0.12 $1.13 $0.96 ($1.22) ($1.23)
Weighted Average Diluted Shares Outstanding		 0.00 0.00 94.57M 32.56M 35.31M 44.01M 110.52M
Weighted Average Basic & Diluted Shares Outstanding		 - - 76.07M 77.88M 80.53M 102.31M 289.64M

Quarterly Income Statements for CompoSecure

This table shows CompoSecure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 7.48 3.70 4.03 11 -42 -27 22 -26 -175 43 -235
Consolidated Net Income / (Loss)		 38 31 17 34 -85 -48 22 -26 -175 43 -235
Net Income / (Loss) Continuing Operations		 38 31 17 34 -85 -48 22 -26 -175 43 -235
Total Pre-Tax Income 		39 35 16 34 -85 -46 34 -67 -185 -8.11 -81
Total Operating Income		 29 31 31 32 29 16 6.00 -2.66 -9.94 -7.18 -56
Total Gross Profit		 49 53 55 56 55 53 29 0.00 0.00 -0.00 0.00
Total Revenue		 97 100 104 109 107 101 60 0.00 0.00 - 0.00
Operating Revenue		 97 100 104 109 107 101 60 0.00 0.00 - 0.00
Total Cost of Revenue		 48 47 49 52 52 48 31 0.00 0.00 0.00 0.00
Operating Cost of Revenue		 48 47 49 52 52 48 31 0.00 0.00 0.00 0.00
Total Operating Expenses		 20 22 24 24 26 37 23 2.66 9.94 7.18 56
Selling, General & Admin Expense		 20 22 24 24 26 37 23 2.66 9.94 7.18 56
Total Other Income / (Expense), net		 10 4.40 -15 2.06 -114 -62 28 -64 -175 -0.93 -22
Interest Expense		 0.00 - 6.54 6.43 6.45 - 1.60 0.00 0.00 - 0.00
Interest & Investment Income		 -5.70 22 1.12 1.11 1.17 21 0.20 0.02 0.29 0.71 0.20
Other Income / (Expense), net		 16 9.88 -9.48 7.38 -109 -62 29 -64 -175 -1.64 -22
Income Tax Expense		 0.95 3.90 -0.84 0.26 0.63 2.14 27 -1.76 30 -16 3.60
Other Gains / (Losses), net		 - - 0.00 0.00 0.00 - 15 39 40 35 -154
Basic Earnings per Share		 $0.39 $0.20 $0.20 $0.44 ($1.10) ($0.76) $0.21 ($0.26) ($1.58) $0.40 ($0.87)
Weighted Average Basic Shares Outstanding		 19.07M 18.66M 20.57M 25.44M 38.21M 44.01M 102.04M 102.32M 110.26M 110.52M 269.99M
Diluted Earnings per Share		 $0.34 $0.22 $0.17 $0.32 ($1.10) ($0.61) $0.07 ($0.26) ($1.58) $0.54 ($0.87)
Weighted Average Diluted Shares Outstanding		 35.76M 35.31M 96.24M 96.64M 38.21M 44.01M 113.27M 102.32M 110.26M 110.52M 269.99M
Weighted Average Basic & Diluted Shares Outstanding		 79.32M 80.53M 80.59M 81.91M 88.13M 102.31M 102.32M 102.38M 125.20M 289.64M 289.86M

Annual Cash Flow Statements for CompoSecure

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 14 -13 8.52 -8.30 28 36 37
Net Cash From Operating Activities		 81 87 78 93 104 130 -23
Net Cash From Continuing Operating Activities		 81 87 78 93 104 130 -23
Net Income / (Loss) Continuing Operations		 81 78 83 132 113 -83 -136
Consolidated Net Income / (Loss)		 81 78 83 132 113 -83 -136
Depreciation Expense		 8.61 9.92 10 8.58 8.39 9.17 1.62
Amortization Expense		 0.67 0.84 1.65 2.35 1.55 1.16 0.07
Non-Cash Adjustments To Reconcile Net Income		 1.21 3.01 3.23 -29 -3.58 193 109
Changes in Operating Assets and Liabilities, net		 -11 -4.52 -21 -21 -15 9.59 2.55
Net Cash From Investing Activities		 -9.64 -7.50 -4.75 -9.05 -11 -9.95 -61
Net Cash From Continuing Investing Activities		 -9.64 -7.50 -4.75 -9.05 -11 -9.95 -61
Purchase of Property, Plant & Equipment		 -9.64 -7.50 -4.75 -9.05 -11 -8.45 -0.39
Other Investing Activities, net		 - - - 0.00 0.00 -1.50 -60
Net Cash From Financing Activities		 -58 -93 -65 -92 -66 -83 121
Net Cash From Continuing Financing Activities		 -58 -93 -65 -92 -66 -83 121
Repayment of Debt		 -30 -14 -247 -32 -23 -15 0.00
Repurchase of Common Equity		 - - - - 0.00 0.00 -12
Payment of Dividends		 -104 -217 -241 -36 -38 -44 0.00
Issuance of Common Equity		 0.00 0.00 61 0.08 1.20 5.00 0.12
Other Financing Activities, net		 0.00 0.00 -15 -24 -5.56 -30 133
Cash Interest Paid		 4.89 5.32 10 21 27 21 2.16
Cash Income Taxes Paid		 - - 0.00 0.86 2.76 4.82 24

Quarterly Cash Flow Statements for CompoSecure

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 1.20 17 14 -20 17 25 -68 -4.70 123 -13 -108
Net Cash From Operating Activities		 25 26 34 32 28 35 3.00 0.04 -12 -14 -53
Net Cash From Continuing Operating Activities		 25 26 34 32 28 35 3.00 0.04 -12 -14 -53
Net Income / (Loss) Continuing Operations		 38 31 17 34 -85 -48 22 -26 -175 43 -235
Consolidated Net Income / (Loss)		 38 31 17 34 -85 -48 22 -26 -175 43 -235
Depreciation Expense		 2.08 2.14 2.22 2.38 2.33 2.24 1.60 - - - 0.00
Non-Cash Adjustments To Reconcile Net Income		 -1.03 -17 14 -1.01 80 102 -40 41 141 -34 178
Changes in Operating Assets and Liabilities, net		 -15 10 -0.02 -3.04 31 -20 20 -15 22 -24 4.40
Net Cash From Investing Activities		 -0.97 -4.28 -1.61 -1.91 -1.98 -4.43 -61 - - - -2,017
Net Cash From Continuing Investing Activities		 -0.97 -4.28 -1.61 -1.91 -1.98 -4.43 -61 - - - -2,017
Purchase of Property, Plant & Equipment		 -0.97 -4.28 -1.61 -1.91 -1.98 -2.93 -0.40 - - - 0.00
Other Investing Activities, net		 - - 0.00 - - - -60 - - - -2,017
Net Cash From Financing Activities		 -23 -4.76 -18 -50 -8.87 -6.20 -10 -4.74 134 1.27 1,961
Net Cash From Continuing Financing Activities		 -23 -4.76 -18 -50 -8.87 -6.20 -10 -4.74 134 1.27 1,961
Payment of Dividends		 -9.35 - -10 -25 -24 - 0.00 - - - -0.70
Issuance of Common Equity		 0.64 0.17 0.11 0.11 2.67 2.10 0.10 - - - 1,962
Other Financing Activities, net		 -0.64 -0.24 -3.48 -21 16 -5.60 -10 -4.74 147 1.27 0.00
Cash Interest Paid		 4.67 8.95 4.18 8.72 4.10 3.62 2.20 - - - 0.00
Cash Income Taxes Paid		 - - - - - - 0.70 - 5.28 7.54 0.00

Annual Balance Sheets for CompoSecure

This table presents CompoSecure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 81 131 163 201 474 517
Total Current Assets		 53 78 97 139 174 120
Cash & Equivalents		 13 22 14 41 77 115
Prepaid Expenses		 1.08 2.60 3.82 5.13 4.16 5.50
Current Deferred & Refundable Income Taxes		 - - - - - 0.00
Plant, Property, & Equipment, net		 28 22 23 25 23 0.00
Total Noncurrent Assets		 0.01 31 43 36 277 397
Long-Term Investments		 - - - - 0.00 126
Noncurrent Deferred & Refundable Income Taxes		 0.00 26 26 24 265 272
Total Liabilities & Shareholders' Equity		 81 131 163 201 474 517
Total Liabilities		 274 539 455 407 617 274
Total Current Liabilities		 42 61 47 41 76 19
Accounts Payable		 2.42 7.06 7.13 5.19 12 0.80
Accrued Expenses		 12 10 10 12 15 1.90
Other Current Liabilities		 3.64 31 13 12 34 16
Total Noncurrent Liabilities		 232 478 408 366 541 255
Other Noncurrent Operating Liabilities		 0.41 103 39 9.51 104 255
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -193 -1,016 -892 -802 -143 243
Total Preferred & Common Equity		 -193 -1,016 -892 -802 -143 243
Preferred Stock		 - 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -193 -1,016 -892 -802 -143 243
Common Stock		 6.15 12 24 39 361 707
Retained Earnings		 -199 -1,028 -925 -847 -507 -451
Treasury Stock		 - - - - 0.00 -12
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 8.28 4.99 2.54 -0.20

Quarterly Balance Sheets for CompoSecure

This table presents CompoSecure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 170 186 181 195 214 213 435 292 317 505 3,414
Total Current Assets		 103 117 112 128 151 136 157 11 5.91 132 23
Cash & Equivalents		 15 23 23 24 55 35 53 9.51 4.81 127 6.50
Prepaid Expenses		 2.82 4.20 4.10 3.91 5.25 3.93 5.25 - 1.10 4.67 4.30
Current Deferred & Refundable Income Taxes		 - - - - - - - - - - 12
Plant, Property, & Equipment, net		 23 24 24 23 25 24 23 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 44 44 45 44 38 53 256 281 311 373 3,391
Long-Term Investments		 - - - - - - - 15 45 84 3,133
Noncurrent Deferred & Refundable Income Taxes		 25 28 28 28 26 41 245 267 267 289 258
Total Liabilities & Shareholders' Equity		 170 186 181 195 214 213 435 292 317 505 3,414
Total Liabilities		 495 477 453 434 411 422 720 380 424 353 298
Total Current Liabilities		 67 59 51 53 42 49 65 47 52 58 25
Accounts Payable		 13 15 6.64 14 4.75 9.43 9.69 4.03 2.64 1.52 1.40
Accrued Expenses		 20 12 11 14 13 12 13 29 15 41 3.10
Other Current Liabilities		 24 10 13 13 11 13 31 9.30 20 0.00 20
Total Noncurrent Liabilities		 428 418 402 381 369 373 656 333 372 295 273
Other Noncurrent Operating Liabilities		 70 53 43 27 24 16 105 84 137 41 273
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -928 -888 -868 -835 -794 -726 -285 -87 -106 152 3,116
Total Preferred & Common Equity		 -928 -888 -868 -835 -794 -726 -285 -87 -106 152 3,116
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -928 -888 -868 -835 -794 -726 -285 -87 -106 152 3,116
Common Stock		 21 26 30 35 41 36 180 206 214 659 3,816
Retained Earnings		 -958 -920 -907 -878 -840 -767 -468 -294 -320 -494 -687
Treasury Stock		 - - - - - - - - - -12 -12
Accumulated Other Comprehensive Income / (Loss)		 9.00 6.63 7.91 7.65 5.44 4.85 2.57 -0.21 -0.21 -0.21 -0.20

Annual Metrics And Ratios for CompoSecure

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - 125,195,366.00
DEI Adjusted Shares Outstanding		 - - - - - - 125,195,366.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - -1.09
Growth Metrics		 - - - - - - -
Profitability Metrics		 - - - - - - -
Net Operating Profit after Tax (NOPAT)		 87 84 82 111 114 75 -9.61
Return On Investment Capital (ROIC_SIMPLE)		 - - - -20.82% -24.90% 134.33% -3.95%
Earnings before Interest and Taxes (EBIT)		 86 83 93 156 140 -65 -225
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 96 94 105 167 150 -55 -224
Valuation Ratios		 - - - - - - -
Leverage & Solvency		 - - - - - - -
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 34 174 17 71 192 -34
Efficiency Ratios		 - - - - - - -
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 50 -42 52 96 -21 3.04
Increase / (Decrease) in Invested Capital		 0.00 50 -92 94 43 -117 24
Book Value per Share		 $0.00 ($6.65) ($35.10) ($11.69) ($10.12) ($1.63) $1.94
Tangible Book Value per Share		 $0.00 ($6.65) ($35.10) ($11.69) ($10.12) ($1.63) $1.94
Total Capital		 0.00 63 -20 66 137 56 243
Total Debt		 0.00 256 388 358 343 200 0.00
Total Long-Term Debt		 0.00 232 375 344 332 188 0.00
Net Debt		 0.00 242 366 344 301 122 -240
Capital Expenditures (CapEx)		 9.64 7.50 4.75 9.05 11 8.45 0.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 22 8.31 50 68 31 -14
Debt-free Net Working Capital (DFNWC)		 0.00 36 30 64 109 109 101
Net Working Capital (NWC)		 0.00 12 18 50 98 98 101
Net Nonoperating Expense (NNE)		 5.45 6.14 -1.14 -21 1.93 158 126
Net Nonoperating Obligations (NNO)		 0.00 242 366 344 301 122 -240
Total Depreciation and Amortization (D&A)		 9.28 11 12 11 9.93 10 1.70
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.91 $1.21 $1.03 ($1.22) ($1.23)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 14.93M 15.37M 18.66M 44.01M 110.52M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.14 $1.13 $0.96 ($1.22) ($1.23)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 94.93M 32.56M 35.31M 44.01M 110.52M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 76.07M 77.88M 80.53M 102.31M 289.64M
Normalized Net Operating Profit after Tax (NOPAT)		 61 59 57 111 114 75 -9.61
Debt Service Ratios		 - - - - - - -
Payout Ratios		 - - - - - - -

Quarterly Metrics And Ratios for CompoSecure

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - 125,195,366.00 289,642,587.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 125,195,366.00 289,642,587.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.35 -0.81
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -6.21% 6.52% 9.12% 10.19% 10.58% 0.96% -42.48% -100.00% -100.00% - -100.00%
EBITDA Growth		 57.04% 36.82% 34.55% 1.16% -262.55% -203.03% 52.00% -259.55% -140.20% - -311.17%
EBIT Growth		 62.02% 40.51% 40.60% 0.13% -278.01% -215.25% 62.18% -270.57% -132.29% - -320.80%
NOPAT Growth		 11.55% 12.15% -1.77% 7.04% -27.53% -59.73% -96.35% -105.89% -134.16% - -3,362.70%
Net Income Growth		 73.79% 38.78% 59.01% 2.71% -324.64% -255.87% 25.88% -177.76% -104.39% - -1,193.02%
EPS Growth		 88.89% 10.00% 54.55% 10.34% -423.53% -377.27% -58.82% -181.25% -43.64% - -1,342.86%
Operating Cash Flow Growth		 -18.55% 144.25% 35.56% 14.83% 13.01% 33.99% -91.08% -99.89% -140.56% - -1,853.33%
Free Cash Flow Firm Growth		 -112.26% 76.89% 71.13% 100.43% 579.24% 888.57% 8,211.08% 3,084.85% -62.77% - -166.08%
Invested Capital Growth		 187.70% 82.80% 78.90% 40.73% -114.46% -122.34% -240.24% -287.27% -423.15% - 79.04%
Revenue Q/Q Growth		 -1.67% 3.11% 4.11% 4.38% -1.32% -5.86% -40.69% -100.00% 0.00% - 0.00%
EBITDA Q/Q Growth		 14.35% -9.52% -43.44% 72.88% -283.74% 42.65% 183.44% -281.47% -176.62% - -778.59%
EBIT Q/Q Growth		 14.24% -9.60% -46.40% 80.88% -303.11% 41.47% 175.42% -290.24% -176.62% - -778.59%
NOPAT Q/Q Growth		 -4.66% -3.50% 20.73% -3.63% -35.46% -46.37% -89.07% -255.71% -274.21% - -674.37%
Net Income Q/Q Growth		 16.32% -18.46% -44.97% 96.78% -354.41% 43.42% 144.44% -221.56% -568.69% - -642.42%
EPS Q/Q Growth		 17.24% -35.29% -22.73% 88.24% -443.75% 44.55% 111.48% -471.43% -507.69% - -261.11%
Operating Cash Flow Q/Q Growth		 -11.34% 6.17% 27.69% -4.45% -12.75% 25.88% -91.50% -98.77% -32,372.97% - -276.01%
Free Cash Flow Firm Q/Q Growth		 -716.79% 29.21% 85.38% 414.04% 1,374.81% 16.48% 50.36% 23.31% -82.76% - -331.02%
Invested Capital Q/Q Growth		 32.21% 22.36% -16.81% 4.58% -113.59% -88.97% -422.25% -39.64% 62.04% - -854.84%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 50.47% 52.95% 53.08% 51.65% 51.72% 52.09% 48.06% 0.00% 0.00% - 0.00%
EBITDA Margin		 48.86% 42.87% 23.29% 38.57% -71.82% -43.75% 61.54% 0.00% 0.00% - 0.00%
Operating Margin		 29.73% 30.56% 29.94% 29.28% 27.15% 15.47% 10.10% 0.00% 0.00% - 0.00%
EBIT Margin		 46.13% 40.45% 20.82% 36.08% -74.26% -46.17% 58.71% 0.00% 0.00% - 0.00%
Profit (Net Income) Margin		 39.27% 31.06% 16.41% 30.95% -79.78% -47.95% 35.93% 0.00% 0.00% - 0.00%
Tax Burden Percent		 97.57% 88.83% 105.15% 99.24% 100.74% 104.62% 63.87% 39.11% 94.67% - 290.48%
Interest Burden Percent		 87.26% 86.43% 74.98% 86.43% 106.64% 99.26% 95.82% 99.97% 99.84% - 104.39%
Effective Tax Rate		 2.43% 11.17% -5.15% 0.76% 0.00% 0.00% 80.24% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 211.60% 143.23% 202.54% 167.06% 238.43% 122.53% 0.00% 0.00% 0.00% - 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 214.58% 144.44% 197.42% 167.71% 202.59% 94.54% 0.00% 0.00% 0.00% - 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -254.70% -187.41% -247.58% -217.37% -228.47% -114.67% 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)		 -43.10% -44.17% -45.05% -50.31% 9.96% 7.87% 55.32% 87.78% 343.57% - -25.92%
Cash Return on Invested Capital (CROIC)		 115.74% 96.04% 130.26% 131.93% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Return on Assets (OROA)		 97.24% 86.81% 41.64% 74.89% -98.85% -57.54% 87.36% 0.00% 0.00% - 0.00%
Return on Assets (ROA)		 82.78% 66.66% 32.83% 64.24% -106.19% -59.75% 53.46% 0.00% 0.00% - 0.00%
Return on Common Equity (ROCE)		 -134.81% -150.38% -155.06% -166.74% 21.29% 21.31% 171.25% 231.48% 343.57% - -25.92%
Return on Equity Simple (ROE_SIMPLE)		 -12.43% 0.00% -14.97% -16.50% 1.33% 0.00% 90.19% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 28 27 33 32 20 11 1.19 -1.86 -6.96 -5.03 -39
NOPAT Margin		 29.00% 27.15% 31.48% 29.06% 19.01% 10.83% 2.00% 0.00% 0.00% - 0.00%
Net Nonoperating Expense Percent (NNEP)		 -2.97% -1.21% 5.11% -0.66% 35.83% 27.99% -16.07% 19.99% 540.77% - -12.39%
Return On Investment Capital (ROIC_SIMPLE)		 - -5.90% -7.09% - - 19.47% -1.37% 1.75% -4.56% -2.07% -1.25%
Cost of Revenue to Revenue		 49.53% 47.05% 46.92% 48.35% 48.28% 47.91% 51.94% 0.00% 0.00% - 0.00%
SG&A Expenses to Revenue		 20.74% 22.39% 23.15% 22.36% 24.56% 36.62% 37.95% 0.00% 0.00% - 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 20.74% 22.39% 23.15% 22.36% 24.56% 36.62% 37.95% 0.00% 0.00% - 0.00%
Earnings before Interest and Taxes (EBIT)		 45 40 22 39 -80 -47 35 -67 -185 -8.82 -78
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 47 43 24 42 -77 -44 37 -67 -185 -8.82 -78
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.98 - 1.59
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.98 - 1.59
Price to Revenue (P/Rev)		 1.27 0.83 1.11 1.34 2.74 2.55 2.95 5.38 13.27 - 206,370.34
Price to Earnings (P/E)		 24.93 16.90 21.11 20.84 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield		 0.00% 0.00% 0.00% 4.41% 2.14% 2.46% 31.97% 24.66% 16.69% - 18.58%
Earnings Yield		 4.01% 5.92% 4.74% 4.80% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 17.90 12.78 16.52 16.30 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Revenue (EV/Rev)		 3.64 3.13 3.29 3.31 3.39 2.84 2.89 5.20 11.95 - 75,549.51
Enterprise Value to EBITDA (EV/EBITDA)		 10.14 8.18 8.45 8.68 44.46 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)		 10.94 8.76 9.02 9.30 65.62 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 12.50 10.69 11.35 11.49 0.00 15.88 18.83 41.36 303.06 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.79 11.73 11.63 11.56 11.79 9.23 11.01 20.90 76.12 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 22.95 17.20 16.27 14.44 0.00 6.22 4.37 5.10 35.42 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 -1.43 -1.67 -1.68 -1.57 -1.15 -1.39 0.00 0.00 0.00 - 0.00
Long-Term Debt to Equity		 -1.38 -1.62 -1.62 -1.50 -1.11 -1.31 0.00 0.00 0.00 - 0.00
Financial Leverage		 -1.19 -1.30 -1.25 -1.30 -1.13 -1.21 -0.89 -0.77 -0.47 - -1.04
Leverage Ratio		 -0.65 -0.73 -0.82 -0.82 -1.20 -1.93 -1.78 -1.68 -7.10 - 1.22
Compound Leverage Factor		 -0.56 -0.63 -0.61 -0.71 -1.28 -1.92 -1.70 -1.68 -7.09 - 1.28
Debt to Total Capital		 334.07% 250.28% 246.46% 276.24% 789.09% 355.78% 0.00% 0.00% 0.00% - 0.00%
Short-Term Debt to Total Capital		 10.13% 7.53% 8.81% 11.32% 24.18% 20.06% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital		 323.95% 242.75% 237.65% 264.92% 764.92% 335.72% 0.00% 0.00% 0.00% - 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 584.68% 435.71% 442.70% 435.29% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 -818.75% -585.99% -589.16% -611.54% -689.09% -255.78% 100.00% 100.00% 100.00% - 100.00%
Debt to EBITDA		 2.47 2.29 2.13 2.10 10.20 -3.63 0.00 0.00 0.00 - 0.00
Net Debt to EBITDA		 2.30 2.02 1.78 1.87 8.56 -2.22 0.00 0.00 0.00 - 0.00
Long-Term Debt to EBITDA		 2.39 2.22 2.06 2.01 9.89 -3.43 0.00 0.00 0.00 - 0.00
Debt to NOPAT		 3.04 2.99 2.86 2.78 -0.12 2.65 0.00 0.00 0.00 - 0.00
Net Debt to NOPAT		 2.83 2.63 2.39 2.48 -0.10 1.62 0.00 0.00 0.00 - 0.00
Long-Term Debt to NOPAT		 2.95 2.90 2.76 2.66 -0.12 2.50 0.00 0.00 0.00 - 0.00
Altman Z-Score		 -2.44 -2.22 -2.05 -1.24 0.07 0.36 1.89 0.61 1.54 - 9.62
Noncontrolling Interest Sharing Ratio		 -212.79% -240.44% -244.24% -231.40% -113.88% -170.83% -209.57% -163.71% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.43 3.40 3.56 2.79 2.43 2.28 0.23 0.11 2.26 - 0.92
Quick Ratio		 1.37 1.99 2.13 1.53 1.49 1.64 0.23 0.09 2.18 - 0.26
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -23 -16 -2.37 7.45 110 128 192 237 41 -29 -127
Operating Cash Flow to CapEx		 2,561.52% 618.32% 2,092.44% 1,684.90% 1,418.15% 1,207.12% 778.04% 0.00% 0.00% - 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -0.36 0.00 742.56 0.00 114.02 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 5.16 0.00 190.11 0.00 1.78 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 4.92 0.00 176.70 0.00 1.55 0.00 0.00 - 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.11 2.15 2.00 2.08 1.33 1.25 1.49 1.01 0.34 - 0.00
Accounts Receivable Turnover		 8.15 10.05 10.75 10.75 9.09 9.57 20.66 0.00 0.00 - 0.00
Inventory Turnover		 3.91 3.83 3.54 3.69 3.74 4.14 0.00 0.00 0.00 - 0.00
Fixed Asset Turnover		 16.76 16.32 16.34 17.08 18.19 17.29 0.00 0.00 0.00 - 0.00
Accounts Payable Turnover		 13.34 29.47 18.61 24.44 16.84 24.06 41.87 21.74 14.17 - 0.00
Days Sales Outstanding (DSO)		 44.77 36.33 33.96 33.96 40.16 38.16 17.66 0.00 0.00 - 0.00
Days Inventory Outstanding (DIO)		 93.39 95.41 103.15 98.93 97.70 88.26 0.00 0.00 0.00 - 0.00
Days Payable Outstanding (DPO)		 27.36 12.38 19.61 14.94 21.68 15.17 8.72 16.79 25.77 - 0.00
Cash Conversion Cycle (CCC)		 110.80 119.36 117.49 117.95 116.18 111.25 8.95 -16.79 -25.77 - 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 78 96 80 83 -11 -21 -112 -156 -59 3.04 -23
Invested Capital Turnover		 7.30 5.28 6.43 5.75 12.54 11.32 -23.49 -7.37 -4.56 - 0.00
Increase / (Decrease) in Invested Capital		 51 43 35 24 -90 -117 -191 -239 -48 24 88
Enterprise Value (EV)		 1,400 1,223 1,316 1,357 1,422 1,196 1,088 1,392 1,920 - 1,813
Market Capitalization		 487 325 442 548 1,148 1,074 1,112 1,442 2,132 - 4,953
Book Value per Share		 ($10.57) ($10.12) ($9.86) ($9.00) ($3.48) ($1.63) ($0.85) ($1.04) $1.49 $1.94 $10.76
Tangible Book Value per Share		 ($10.57) ($10.12) ($9.86) ($9.00) ($3.48) ($1.63) ($0.85) ($1.04) $1.49 $1.94 $10.76
Total Capital		 102 137 135 119 41 56 -87 -106 152 243 3,116
Total Debt		 341 343 332 328 326 200 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 331 332 320 314 316 188 0.00 0.00 0.00 0.00 0.00
Net Debt		 317 301 277 292 274 122 -24 -50 -212 -240 -3,140
Capital Expenditures (CapEx)		 0.97 4.28 1.61 1.91 1.98 2.93 0.39 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 62 68 65 66 50 31 -46 -51 -54 -14 -8.50
Debt-free Net Working Capital (DFNWC)		 86 109 120 101 102 109 -36 -46 74 101 -2.00
Net Working Capital (NWC)		 75 98 108 87 92 98 -36 -46 74 101 -2.00
Net Nonoperating Expense (NNE)		 -9.95 -3.91 16 -2.05 106 59 -20 24 168 -48 196
Net Nonoperating Obligations (NNO)		 317 301 277 292 274 122 -24 -50 -212 -240 -3,140
Total Depreciation and Amortization (D&A)		 2.64 2.42 2.57 2.70 2.62 2.44 1.70 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 16.10% 17.28% 16.30% 16.01% 11.81% 7.46% -12.16% -18.94% -33.48% - -35,416.67%
Debt-free Net Working Capital to Revenue		 22.29% 27.83% 30.11% 24.66% 24.36% 25.88% -9.64% -17.14% 45.78% - -8,333.33%
Net Working Capital to Revenue		 19.60% 25.19% 27.13% 21.37% 21.98% 23.20% -9.64% -17.14% 45.78% - -8,333.33%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.39 $0.20 $0.20 $0.44 ($1.10) ($0.76) $0.21 ($0.26) ($1.58) $0.40 ($0.87)
Adjusted Weighted Average Basic Shares Outstanding		 19.07M 18.66M 20.57M 25.44M 38.21M 44.01M 102.04M 102.32M 110.26M 110.52M 269.99M
Adjusted Diluted Earnings per Share		 $0.34 $0.22 $0.17 $0.32 ($1.10) ($0.61) $0.07 ($0.26) ($1.58) $0.54 ($0.87)
Adjusted Weighted Average Diluted Shares Outstanding		 35.76M 35.31M 96.24M 96.64M 38.21M 44.01M 113.27M 102.32M 110.26M 110.52M 269.99M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 79.32M 80.53M 80.59M 81.91M 88.13M 102.31M 102.32M 102.38M 125.20M 289.64M 289.86M
Normalized Net Operating Profit after Tax (NOPAT)		 28 27 22 32 20 11 4.23 -1.86 -6.96 -5.03 -39
Normalized NOPAT Margin		 29.00% 27.15% 20.95% 29.06% 19.01% 10.83% 7.07% 0.00% 0.00% - 0.00%
Pre Tax Income Margin		 40.25% 34.96% 15.61% 31.18% -79.19% -45.83% 56.25% 0.00% 0.00% - 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 3.31 0.00 -537.57 0.00 20.81 0.00 0.00 - 0.00
NOPAT to Interest Expense		 0.00 0.00 5.01 0.00 137.60 0.00 0.71 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 3.07 0.00 -550.98 0.00 20.58 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 4.76 0.00 124.19 0.00 0.48 0.00 0.00 - 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 37.66% 34.09% 32.64% 37.12% -1,570.32% -71.38% -62.49% -6.28% 0.00% - -0.18%
Augmented Payout Ratio		 37.66% 34.09% 32.64% 37.12% -1,570.32% -71.38% -62.49% -6.28% 0.00% - -0.18%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, investor-focused synthesis of CompoSecure, Inc. (CMPO) using the most recent quarterly data across the last four years. The standout development is a clear quarterly profit in Q4 2025, paired with solid balance-sheet liquidity, but with ongoing operating-cash-flow challenges.

  • Strong Q4 2025 profitability: Net income from continuing operations of $43.324 million, with Basic earnings per share of $0.40 and Diluted earnings per share of $0.54, marking a material quarterly improvement.
  • Net income attributable to common shareholders in Q4 2025 was $43.324 million, aligning with the reported net income and signaling earnings reach for equity holders.
  • Balance-sheet snapshot from the latest available sizeable quarter (Q3 2025): Cash & Equivalents of $127.362 million, Total Current Assets of $132.027 million, and Total Assets of $505.475 million, indicating solid liquidity and a sizable asset base.
  • Debt profile remains favorable in Q3 2025: Long-Term Debt stood at $0, suggesting a light leverage position and potential financing flexibility if needed.
  • Q4 2025 includes Other gains / (losses), net of $35.415 million, which contributed positively to pretax income and supported the quarterly net income trajectory.
  • Cash flow from continuing operating activities was negative in Q4 2025 at $(13.989) million, indicating cash-generation challenges despite the positive quarterly net income.
  • Trailing-quarter operating cash flow has been negative (e.g., Q3 2025: $(11.941) million; Q4 2025: $(13.989) million), suggesting working-capital or non-cash adjustments weigh on near-term liquidity even as profitability improves.
  • Cumulative profitability headwinds show up in the balance sheet: Retained Earnings were negative (as of Q3 2025: $(494.409) million), even though Total Equity was about $152.469 million, signaling a long history of losses prior to the latest profitability uptick.
  • Leverage risk on the books: Total Liabilities around $353.006 million versus Total Equity around $152.469 million (Q3 2025), indicating a leveraged balance sheet that could stress resilience if operating performance deteriorates.
  • Shareholder metrics in Q4 2025 show roughly 110.5 million weighted-average shares outstanding on both a basic and diluted basis, with Basic EPS of $0.40 and Diluted EPS of $0.54, a neutral factor for assessing per-share valuation alongside the earnings pickup.
05/12/26 01:51 PM ETAI Generated. May Contain Errors.

CompoSecure Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CompoSecure's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

CompoSecure's net income appears to be on a downward trend, with a most recent value of -$136.01 million in 2025, falling from $81.47 million in 2019. The previous period was -$83.16 million in 2024. Find out what analysts predict for CompoSecure in the coming months.

CompoSecure's total operating income in 2025 was -$13.73 million, based on the following breakdown:
  • Total Gross Profit: $28.75 million
  • Total Operating Expenses: $42.48 million

Over the last 6 years, CompoSecure's total revenue changed from $243.29 million in 2019 to $59.82 million in 2025, a change of -75.4%.

CompoSecure's total liabilities were at $274.10 million at the end of 2025, a 55.6% decrease from 2024, and a 0.1% increase since 2020.

In the past 5 years, CompoSecure's cash and equivalents has ranged from $13.42 million in 2020 to $114.60 million in 2025, and is currently $114.60 million as of their latest financial filing in 2025.

Over the last 6 years, CompoSecure's book value per share changed from 0.00 in 2019 to 1.94 in 2025, a change of 194.2%.


Related Companies

Financial statements for NASDAQ:CMPO last updated on 5/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targe...
Equiscreen | Sponsoredtc pixel
Rise of the… petroyuan?
On February 28th, Iran installed a yuan-denominated toll at the Strait of Hormuz - the chokepoint for one in e...
Golden Portfolio | Sponsoredtc pixel
BSEM: From OTC to Nasdaq Contender!
BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...
Huge Alerts | Sponsoredtc pixel
Read this or regret it forever
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
If You Have $50k+ on Coinbase, This Will Ruin Your Day
In 2009, Greece's debt-to-GDP ratio hit 130%. Within 24 months... Pensions were slashed 40% overnight. Bank ac...
Decentralized Masters | Sponsoredtc pixel
SpaceX Launches Strange 'Dark Energy' Across America
SpaceX is deploying a newly permitted energy technology - one that analyst Joel Litman calls 'Dark Energy' - t...
Altimetry | Sponsoredtc pixel